Zanidatamab
Colorectal Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Gastroesophageal Cancer, Urothelial Carcinoma, Salivary Gland Cancer, Her-2 Protein Overexpression
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
―